Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2000
09/21/2000CA2365092A1 Sorbitol dehydrogenase, gene encoding the same and use thereof
09/21/2000CA2364941A1 Novel protein and its use
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364667A1 Recombinant haemophilus influenzae adhesin proteins
09/21/2000CA2364650A1 50 human secreted proteins
09/21/2000CA2364637A1 50 human secreted proteins
09/21/2000CA2364635A1 47 human secreted proteins
09/21/2000CA2364630A1 50 human secreted proteins
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2364580A1 Plants having modified reproductive capacity
09/21/2000CA2364549A1 50 human secreted proteins
09/21/2000CA2363686A1 Ve protein and nucleic acid sequences, compositions, and methods for plant pathogen resistance
09/21/2000CA2363496A1 Differential expression of organellar gene products
09/21/2000CA2363022A1 49 human secreted proteins
09/21/2000CA2363019A1 49 human secreted proteins
09/21/2000CA2362897A1 Plant centromeres
09/21/2000CA2362771A1 Genetic analysis
09/21/2000CA2361277A1 49 human secreted proteins
09/21/2000CA2328139A1 Photoinhibitory promoter
09/20/2000EP1037158A2 Methods and apparatus for analyzing gene expression data
09/20/2000EP1036847A1 Oligonucleotide primers for efficient reverse transcription of Hepatitis C Virus (HCV) RNA and methods of use thereof
09/20/2000EP1036845A2 Downstream genes of tumor suppressor WT1
09/20/2000EP1036844A1 Examination method, examination reagent and remedy for diseases caused by variation in lkb1 gene
09/20/2000EP1036843A1 DNA molecule encoding an aminopeptidase, and method of producing the aminopeptidase
09/20/2000EP1036842A2 Use of cyanobacterial fructose-1,6-bisphosphatase to improve growth of plants
09/20/2000EP1036327A2 Hla-e binding
09/20/2000EP1036323A1 A bacterial multi-hybrid system and applications
09/20/2000EP1036202A2 Method for identifying nucleic acids by means of matrix-assisted laser desorption/ionisation mass spectrometry
09/20/2000EP1036201A2 Method for detecting apoptosis using fret labeled oligonucleotides
09/20/2000EP1036199A2 Cancer susceptibility mutations of brca1
09/20/2000EP1036198A1 Method for creating polynucleotide and polypeptide sequences
09/20/2000EP1036197A1 Cancer susceptibility mutations of brca2
09/20/2000EP1036195A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof
09/20/2000EP1036188A1 ribG
09/20/2000EP1036186A1 Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes
09/20/2000EP1036185A1 Proteinase inhibitor fusion proteins
09/20/2000EP1036184A1 Genetic method
09/20/2000EP1036183A1 Mutations in atp-dependent transposition proteins that reduce target-site specificity
09/20/2000EP1036182A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
09/20/2000EP1036181A1 The process for expression and production of recombinant protein gp90 derived from glicoprotein envelop of equine infectious anemia virus eiav
09/20/2000EP1036180A2 Circovirus sequences related to piglet weight loss disease (pwd)
09/20/2000EP1036179A1 Method for preparing polypeptides with appropriate glycosilation
09/20/2000EP1036178A1 Identification of lysolipid receptors involved in inflammatory response
09/20/2000EP1036177A1 Novel vectors and genes exhibiting increased expression
09/20/2000EP1036176A2 Methods for the degradation and detoxification of organic material using urine produced by transgenic animals
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036174A2 Novel peptide, apoep1.b, compositions and uses thereof
09/20/2000EP1036173A2 Methods and means for inducing apoptosis by interfering with bip-like proteins
09/20/2000EP1036172A1 SEQUENCES CODING FOR kin17 PROTEIN AND THEIR APPLICATIONS
09/20/2000EP1036171A2 Molecules interacting with apoptin
09/20/2000EP1036170A1 T-type voltage-gated calcium channels and method of using same
09/20/2000EP1036169A1 Nucleic acid mediated rna tagging and rna revision
09/20/2000EP1036168A1 Purification and microsequencing of hyaluronidase isozymes
09/20/2000EP1036167A2 Nuclear targeting by means of streptococcal protein h
09/20/2000EP1036165A1 Human rnase h and compositions and uses thereof
09/20/2000EP1036164A1 Chemokine alpha-5
09/20/2000EP1036162A1 Engraftable neural progenitor and stem cells for brain tumor therapy
09/20/2000EP1036160A1 Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain
09/20/2000EP1036159A1 Method for purifying plasmid dna and plasmid dna substantially free of genomic dna
09/20/2000EP1036095A1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
09/20/2000EP1036091A1 5t4 tumour-associated antigen for use in tumour immunotherapy
09/20/2000EP1036087A1 Secreted proteins and polynucleotides encoding them
09/20/2000EP1036086A1 Caspase-14 polypeptides
09/20/2000EP1036085A1 Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics
09/20/2000EP1036082A2 Isolation of nucleic acids
09/20/2000EP1035870A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
09/20/2000EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
09/20/2000EP1035864A2 Methods and compositions for the treatment of psoriasis
09/20/2000EP1035863A1 An over-expressing homologous antigen vaccine and a method of making the same
09/20/2000EP1035856A1 Isolated dna encoding human h3 histamine receptor
09/20/2000EP0854883A4 Developmentally-regulated endothelial cell locus-1
09/20/2000EP0832119B1 Anti-fungal and anti-bacterial histatin-based peptides
09/20/2000EP0775211B1 Fumonisin detoxification enzymes
09/20/2000EP0766735B1 Class bi and ci scavenger receptors
09/20/2000EP0764030B1 Composition containing autoantibodies for tumor therapy and prophylaxis
09/20/2000EP0742834B1 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
09/20/2000EP0672057B1 Analogs of pth
09/20/2000EP0600865B1 Xylanase production
09/20/2000EP0586549B1 Selecting ligand agonists and antagonists
09/20/2000EP0504327B1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof
09/20/2000CN1267333A Expression of fructose 1,6-bisphosphate aldolase in transgenic plants
09/20/2000CN1267332A Method for producing polyketides
09/20/2000CN1267331A Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
09/20/2000CN1267307A Interleukin-18 binding proteins, their preparation and use
09/20/2000CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b
09/20/2000CN1267223A Carcinostatic agents
09/20/2000CN1267089A Single-point strobed micro electromagnetic units array chip or electromagnetic biologic chip and application thereof
09/20/2000CN1266905A Method for producing L-amino acid by fermentation with corynebacteria
09/20/2000CN1266903A Recombined xylanase, its preparing process and its application
09/20/2000CN1266902A Human membrane translocator and its coding sequence
09/20/2000CN1266901A I-type isomer of human steroid 5 alpha reductase and its coding sequence
09/20/2000CN1266900A cDNA sequences of ox Fc 'gamma' RI,Fc 'gamma' RIII and CD14
09/20/2000CN1266899A Precursor heteromorphic protein of human calcium binding protein and its coding sequence
09/20/2000CN1266898A Human carboxypeptidase precursor protein and its coding sequence
09/20/2000CN1266714A Humanized antibody
09/20/2000CN1056649C 枯草杆菌蛋白酶变异体 Subtilisin variant
09/20/2000CN1056648C Hyperthermostable beta-galactosidase gene
09/20/2000CN1056618C Acylated insulin and pharmaceutical composition contg. same
09/20/2000CN1056617C Melanoma-inhibiting protein